clinical trial · NCT06963320
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Circulatory DiseaseH001 Capsule 200mg-qdEnoxaparin Sodium InjectionH001 Capsule 300mg-qdH001 Capsule 200mg-bid
brief summary
This study is a multicenter, randomized, open-label, positive-controlled Phase II clinical study to evaluate the efficacy and safety of H001 capsules in the prevention of venous thromboembolism (VTE) in subjects undergoing Total Knee Arthroplasty.
started
Jan 20, 2025
primary completion
Jun 30, 2025
completion
Jul 30, 2025
last updated
May 9, 2025
official title
A Multicenter, Randomized, Open-label, Positive-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of H001 Capsules in the Prevention of Venous Thromboembolism (VTE) in Subjects Undergoing Total Knee Arthroplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol